Location: Zurich, Switzerland
CIK: 0001595430 · Show all filings
Period: Q4 2025 (← Previous) (Next →)
Filing Date: Feb 17, 2026
Total Value: $1.034B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RVMD | REVOLUTION MEDICINES INC | 7,601,087 | $605M | 58.5% | $40.59 | +61.5% | COM | 76155X100 |
| TYRA | TYRA BIOSCIENCES INC | 4,055,861 | $107M | 10.3% | $12.94 | +41.9% | COM | 90240B106 |
| TNGX | TANGO THERAPEUTICS INC | 7,266,081 | $64.38M | 6.2% | $3.92 | +119.6% | COM | 87583X109 |
| ORIC | ORIC PHARMACEUTICALS INC | 7,162,637 | $58.59M | 5.7% | $8.21 | +40.2% | COM | 68622P109 |
| RLAY | RELAY THERAPEUTICS INC | 4,701,506 | $39.77M | 3.8% | $4.50 | +58.5% | COM | 75943R102 |
| ZYME | ZYMEWORKS INC | 1,113,946 | $29.33M | 2.8% | $13.64 | +59.9% | COM | 98985Y108 |
| ALMS | ALUMIS INC | 2,915,998 | $28.46M | 2.8% | $5.28 | +32.3% | COM | 022307102 |
| KYMR | KYMERA THERAPEUTICS INC | 278,896 | $21.7M | 2.1% | $34.43 | +96.1% | COM | 501575104 |
| ENGN | ENGENE HOLDINGS INC | 2,124,943 | $19.19M | 1.9% | $8.01 | 0.0% | COM | 29286M105 |
| — | MERSANA THERAPEUTICS INC | 482,689 | $13.96M | 1.3% | $7.76 | — | COM | 59045L205 |
| CGEM | CULLINAN THERAPEUTICS INC | 1,141,145 | $11.81M | 1.1% | $9.60 | -6.0% | COM | 230031106 |
| CNTX | CONTEXT THERAPEUTICS INC | 7,419,355 | $10.91M | 1.1% | $0.87 | +34.2% | COM | 21077P108 |
| SPRY | ARS PHARMACEUTICALS INC | 660,703 | $7.697M | 0.7% | $12.03 | -19.2% | COM | 82835W108 |
| ARVN | ARVINAS INC | 539,394 | $6.397M | 0.6% | $15.67 | -30.3% | COM | 04335A105 |
| SLN | SILENCE THERAPEUTICS PLC | 952,400 | $5.791M | 0.6% | $2.82 | — | ADS | 82686Q101 |
| GLUE | MONTE ROSA THERAPEUTICS INC | 279,237 | $4.378M | 0.4% | $13.48 | 0.0% | COM | 61225M102 |